LABORATORIO ELEA PHOENIX S.A.

Avenida Gral. Juan Gregorio Lemos 2809, Los Polvorines, Buenos Aires, Argentinactbe.cnpem.brEstablished: 2010-01-01

Also known as:

laboratorio elea

Clinical Trials

0 active

Approvals

Total approvals

Agencies

Regulatory bodies

Founded

2010

Overview

Trial Phase Distribution

Phase

Trials

Phase 2

47.1%

Phase 3

23.5%

Phase 4

17.6%

Phase 1

11.8%

Trial Status Distribution

Completed

76.5%

Recruiting

17.6%

Terminated

5.9%

Clinical Trials

Trials sponsored by this organization (17)

Clinical Trial with Cannabidiol (Kanbis®) for Parkinson Disease Symptoms

Phase 2

Recruiting

interventional

Nov 202488 participants

Double-blind Study to Evaluate the PK, Efficacy, Safety and Immunogenicity of MB12 Versus Keytruda® in Stage IV NSCLC

Phase 3

Recruiting

interventional

Aug 2023174 participants

Shorter Benznidazole Regimens Compared to the Standard Regimen for Chagas Disease

Phase 3

Recruiting

interventional

Jul 2021300 participants

Clinical Trial to Evaluate the Efficacy, Immunogenicity and Safety of the Inactivated SARS-CoV-2 Vaccine (COVID-19)

Phase 3

Completed

interventional

Sep 20203,000 participants

Telmisartan for Treatment of COVID-19 Patients

Phase 4

Completed

interventional

May 2020400 participants

Ivermectin Effect on SARS-CoV-2 Replication in Patients With COVID-19

Phase 2

Completed

interventional

May 202045 participants

Bioequivalence Study of Two Extended Release Formulations Containing 50 mg of Quetiapine.

Phase 4

Completed

interventional

Mar 201724 participants

Safety and Clinical Effectiveness of Intravitreal Bevacizumab (Lumiere®) in Patients With Wet Age-related Macular Degeneration (Wet AMD)

Phase 3

Completed

interventional

Feb 201722 participants

Page 1 of 3

Approvals

No approval data available

News

No news articles found

Back to Organizations